News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Roemer Alan S.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| Roemer Alan S. (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 06/16/2023 |
4
| Roemer Alan S. (Director) has filed a Form 4 on IN8BIO, INC.|
Txns:
| Granted 85,000 options to buy
@ $2.12, valued at
$180.2k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Roemer Alan S. (Director) has filed a Form 4 on IN8BIO, INC.|
Txns:
| Granted 86,258 options to buy
@ $6.8, valued at
$586.6k
|
|
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Roemer Alan S. (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Converted 85,016 shares
@ $0
Converted 4,110 shares
@ $0
Converted 26,590 shares
@ $0
Converted 12,268 shares
@ $0
Converted 85,016 preferred shares
@ $0
Converted 4,110 options to buy
@ $0
Converted 26,590 options to buy
@ $0
Converted convertible notes
@ $0 |
|
| 02/16/2021 |
4
| Roemer Alan S. (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 9,556 options to buy
@ $17, valued at
$162.5k
|
|
|
|